Symbols / LFVN Stock $5.27 +2.33% LifeVantage Corporation

Consumer Defensive • Packaged Foods • United States • NCM
LFVN (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Consumer Defensive
Industry Packaged Foods
CEO Mr. Michael A. Beindorff
Exch · Country NCM · United States
Market Cap 66.49M
Enterprise Value 64.21M
Income 5.75M
Sales 195.32M
FCF (ttm) 2.03M
Book/sh 2.58
Cash/sh 0.99
Employees 232
Insider 10d —
IPO Apr 07, 1994
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 40.00%
P/E 11.71
Forward P/E 7.69
PEG 0.36
P/S 0.34
P/B 2.04
P/C —
EV/EBITDA 6.42
EV/Sales 0.33
Quick Ratio 0.85
Current Ratio 1.96
Debt/Eq 30.61
LT Debt/Eq —
EPS (ttm) 0.45
EPS next Y 0.69
EPS Growth -58.50%
Revenue Growth -25.20%
EPS Gr Q/Q -60.70%
Rev Gr Q/Q —
Earnings (next) 2026-05-06
Earnings (prior) 2026-05-06
ROA 6.44%
ROE 17.08%
ROIC —
Gross Margin 78.14%
Oper. Margin 4.07%
Profit Margin 2.94%
Shs Outstand 12.62M
Shs Float 8.88M
Insider Own 16.43%
Instit Own 69.82%
Short Float 38.64%
Short Ratio 21.63
Short Interest 3.85M
52W High 15.00
vs 52W High -64.87%
52W Low 3.90
vs 52W Low 35.13%
Beta 0.55
Impl. Vol. 12.50%
Rel Volume 1.01
Avg Volume 168.60K
Volume 170.62K
Target (mean) $8.00
Tgt Median $8.00
Tgt Low $5.00
Tgt High $11.00
# Analysts 2
Recom None
Prev Close $5.15
Price $5.27
Change 2.33%
About

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, pre and pro-biotics and skin and hair care products internationally. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; LifeVantage Daily Wellness, a dietary supplement to strengthen immune health; LifeVantage Rise AM and Reset PM System that provides the body with the right nutrients; LifeVantage D3+, a dietary supplement that provides vitamin D3 and K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health; PhysIQ Fat Burn to support weight management; PhysIQ Prebiotic is a dietary supplement designed to support the good bacteria in the gut and a healthy microbiome; MindBody GLP-1 System, a dietary supplement that combines two products, MB Core and MB Enhance, which are designed to support weight management and wellness by activating GLP-1 naturally and balancing signals along the gut-brain axis; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. It also provides anti-aging skin care products, such as liquid collagen, facial cleansers, eye cream, moisturizing cream, sunscreen, perfecting lotions, and hand creams, as well as shampoos, nourishing conditioners, and scalp serums under the TrueScience brand name. It sells its products through its website and network of independent consultants. LifeVantage Corporation is based in Lehi, Utah.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$8.00
Mean price target
2. Current target
$5.27
Latest analyst target
3. DCF / Fair value
$2.90
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$5.27
Low
$5.00
High
$11.00
Mean
$8.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-07 down Lake Street Buy → Hold $5
2026-02-18 main Freedom Broker Buy → Buy $11
2025-11-14 main Freedom Broker Buy → Buy $17
2025-01-14 init Craig-Hallum — → Buy $35
2024-12-19 init Lake Street — → Buy $26
2014-02-12 init Imperial Capital — → In-Line $2
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-16 LEWIS DARWIN K Director — 1,055 $5.23 $5,518
2026-03-02 JUDD DAYTON R Director — 33,197 $4.53 $152,422
2026-02-09 LEWIS DARWIN K Director — 3,955 $5.22 $20,651
2025-12-15 LEWIS DARWIN K Director — 805 $6.54 $5,265
2025-11-25 BEINDORFF MICHAEL A. Director — 7,819 $0.00 $0
2025-11-19 BEINDORFF MICHAEL A. Director — 12,607 $6.42 $80,934
2025-11-07 BEINDORFF MICHAEL A. Director — 36,000 $6.92 $249,582
2025-11-06 BEINDORFF MICHAEL A. Director — 13,531 $7.76 $105,001
2025-11-06 GREER RAYMOND B Director — 13,531 $7.76 $105,001
2025-11-06 JUDD DAYTON R Director — 13,531 $7.76 $105,001
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total Revenue
228.53
+14.17%
200.16
-6.20%
213.40
+3.41%
206.36
Operating Revenue
200.26
+13.75%
176.06
+4.05%
169.21
+6.76%
158.49
Cost Of Revenue
44.86
+8.26%
41.44
-4.49%
43.39
+13.89%
38.10
Reconciled Cost Of Revenue
44.86
+8.26%
41.44
-4.49%
43.39
+13.89%
38.10
Gross Profit
183.67
+15.71%
158.72
-6.64%
170.01
+1.04%
168.26
Operating Expense
171.47
+11.06%
154.39
-6.85%
165.75
+3.15%
160.69
Selling General And Administration
69.21
+1.07%
68.47
-3.65%
71.06
+12.05%
63.42
Selling And Marketing Expense
—
85.92
-9.26%
94.69
-2.65%
97.26
General And Administrative Expense
69.21
+1.07%
68.47
-3.65%
71.06
+12.05%
63.42
Other Gand A
69.21
+1.07%
68.47
-3.65%
71.06
+12.05%
63.42
Other Operating Expenses
102.26
+19.02%
85.92
-9.26%
94.69
-2.65%
97.26
Total Expenses
216.33
+10.47%
195.83
-6.36%
209.14
+5.21%
198.78
Operating Income
12.20
+181.60%
4.33
+1.71%
4.26
-43.78%
7.58
Total Operating Income As Reported
12.20
+181.60%
4.33
+1.71%
4.26
-43.78%
7.58
EBITDA
15.36
+94.05%
7.91
+0.96%
7.84
-1.56%
7.96
Normalized EBITDA
15.73
+88.62%
8.34
+1.60%
8.21
-24.51%
10.88
Reconciled Depreciation
3.16
-11.87%
3.58
+0.06%
3.58
+9.75%
3.26
EBIT
12.20
+181.60%
4.33
+1.71%
4.26
-9.40%
4.70
Total Unusual Items
-0.38
+11.42%
-0.43
-15.01%
-0.37
+87.20%
-2.92
Total Unusual Items Excluding Goodwill
-0.38
+11.42%
-0.43
-15.01%
-0.37
+87.20%
-2.92
Special Income Charges
—
—
0.00
+100.00%
-2.21
Write Off
—
—
0.00
-100.00%
2.21
Net Income
9.80
+233.84%
2.94
+15.63%
2.54
-18.59%
3.12
Pretax Income
12.24
+181.45%
4.35
+8.78%
4.00
-14.75%
4.69
Net Non Operating Interest Income Expense
0.43
+0.23%
0.43
+117.17%
0.20
+2080.00%
-0.01
Interest Expense Non Operating
—
—
—
0.01
Net Interest Income
0.43
+0.23%
0.43
+117.17%
0.20
+2080.00%
-0.01
Interest Expense
—
—
—
0.01
Interest Income Non Operating
0.43
+0.23%
0.43
+117.17%
0.20
—
Interest Income
0.43
+0.23%
0.43
+117.17%
0.20
—
Other Income Expense
-0.39
+6.07%
-0.41
+10.04%
-0.46
+84.06%
-2.87
Other Non Operating Income Expenses
-0.01
-141.18%
0.02
+120.00%
-0.09
-307.32%
0.04
Gain On Sale Of Security
-0.38
+11.42%
-0.43
-15.01%
-0.37
+47.46%
-0.71
Tax Provision
2.44
+72.54%
1.41
-3.15%
1.46
-7.13%
1.57
Tax Rate For Calcs
0.00
-38.70%
0.00
-11.01%
0.00
+8.96%
0.00
Tax Effect Of Unusual Items
-0.08
+45.70%
-0.14
-2.35%
-0.14
+86.06%
-0.98
Net Income Including Noncontrolling Interests
9.80
+233.84%
2.94
+15.63%
2.54
-18.59%
3.12
Net Income From Continuing Operation Net Minority Interest
9.80
+233.84%
2.94
+15.63%
2.54
-18.59%
3.12
Net Income From Continuing And Discontinued Operation
9.80
+233.84%
2.94
+15.63%
2.54
-18.59%
3.12
Net Income Continuous Operations
9.80
+233.84%
2.94
+15.63%
2.54
-18.59%
3.12
Normalized Income
10.11
+213.31%
3.23
+16.20%
2.78
-45.10%
5.06
Net Income Common Stockholders
9.80
+233.84%
2.94
+15.63%
2.54
-18.59%
3.12
Diluted EPS
—
0.23
+15.00%
0.20
-16.67%
0.24
Basic EPS
—
0.24
+20.00%
0.20
-16.67%
0.24
Basic Average Shares
—
12.46
-0.79%
12.56
-2.55%
12.89
Diluted Average Shares
—
12.99
+3.33%
12.57
-3.84%
13.07
Diluted NI Availto Com Stockholders
9.80
+233.84%
2.94
+15.63%
2.54
-18.59%
3.12
Gain On Sale Of PPE
—
—
—
0.00
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total Assets
71.96
+19.34%
60.30
-8.81%
66.12
-6.48%
70.71
Current Assets
50.89
+35.19%
37.65
-14.99%
44.28
-5.69%
46.96
Cash Cash Equivalents And Short Term Investments
20.20
+19.63%
16.89
-21.84%
21.61
+7.01%
20.19
Cash And Cash Equivalents
20.20
+19.63%
16.89
-21.84%
21.61
+7.01%
20.19
Receivables
3.93
+20.45%
3.26
+76.04%
1.85
-63.60%
5.09
Accounts Receivable
3.29
+11.70%
2.95
+82.94%
1.61
-51.71%
3.34
Taxes Receivable
0.64
+102.88%
0.31
+29.88%
0.24
-86.24%
1.75
Inventory
20.67
+37.29%
15.05
-6.33%
16.07
-2.42%
16.47
Raw Materials
2.93
-8.84%
3.21
-18.01%
3.92
+3.21%
3.80
Finished Goods
17.74
+49.81%
11.84
-2.57%
12.15
-4.11%
12.67
Prepaid Assets
—
—
—
5.21
Other Current Assets
6.09
+149.49%
2.44
-48.60%
4.75
-8.68%
5.21
Total Non Current Assets
21.06
-7.01%
22.65
+3.73%
21.84
-8.04%
23.75
Net PPE
14.25
-18.03%
17.38
-2.48%
17.82
-13.22%
20.54
Gross PPE
31.66
-0.73%
31.89
-0.26%
31.98
-11.73%
36.23
Accumulated Depreciation
-17.41
-20.00%
-14.51
-2.54%
-14.15
+9.79%
-15.69
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
1.52
+0.20%
1.52
-0.65%
1.53
+11.38%
1.37
Other Properties
25.04
-1.17%
25.34
-1.47%
25.71
-10.78%
28.82
Leases
5.10
+1.21%
5.04
+6.46%
4.73
-21.54%
6.03
Goodwill And Other Intangible Assets
0.24
-24.15%
0.32
-29.01%
0.46
-22.49%
0.59
Other Intangible Assets
0.24
-24.15%
0.32
-29.01%
0.46
-22.49%
0.59
Investments And Advances
—
—
—
0.00
Non Current Deferred Assets
5.97
+39.88%
4.27
+42.69%
2.99
+132.04%
1.29
Non Current Deferred Taxes Assets
5.97
+39.88%
4.27
+42.69%
2.99
+132.04%
1.29
Other Non Current Assets
0.60
-11.62%
0.68
+19.51%
0.57
-57.31%
1.33
Total Liabilities Net Minority Interest
37.32
+8.77%
34.31
+9.00%
31.47
-19.69%
39.19
Current Liabilities
27.22
+22.00%
22.31
+13.77%
19.61
-23.78%
25.73
Payables And Accrued Expenses
19.31
+7.11%
18.03
+27.38%
14.15
-35.90%
22.08
Payables
14.48
-5.43%
15.32
+21.50%
12.61
-27.61%
17.41
Accounts Payable
5.06
-19.53%
6.29
+48.80%
4.22
-46.67%
7.92
Other Payable
7.24
+10.17%
6.57
-1.23%
6.65
-8.70%
7.29
Current Accrued Expenses
4.82
+77.94%
2.71
+75.36%
1.55
-66.85%
4.66
Pensionand Other Post Retirement Benefit Plans Current
5.33
+230.85%
1.61
-48.07%
3.10
+219.46%
0.97
Total Tax Payable
2.19
-11.02%
2.46
+42.20%
1.73
-21.58%
2.21
Income Tax Payable
0.00
-100.00%
0.20
0.00
-100.00%
0.45
Current Debt And Capital Lease Obligation
1.87
+3.09%
1.81
+19.07%
1.52
-41.52%
2.60
Current Capital Lease Obligation
1.87
+3.09%
1.81
+19.07%
1.52
-41.52%
2.60
Current Deferred Liabilities
0.71
-17.33%
0.86
+3.12%
0.83
+969.23%
0.08
Current Deferred Revenue
0.71
-17.33%
0.86
+3.12%
0.83
+969.23%
0.08
Total Non Current Liabilities Net Minority Interest
10.10
-15.83%
12.00
+1.13%
11.87
-11.86%
13.46
Long Term Debt And Capital Lease Obligation
9.81
-16.86%
11.80
+2.03%
11.57
-12.07%
13.15
Long Term Capital Lease Obligation
9.81
-16.86%
11.80
+2.03%
11.57
-12.07%
13.15
Other Non Current Liabilities
0.29
+45.96%
0.20
-33.78%
0.30
-2.92%
0.31
Stockholders Equity
34.64
+33.28%
25.99
-24.99%
34.65
+9.94%
31.52
Common Stock Equity
34.64
+33.28%
25.99
-24.99%
34.65
+9.94%
31.52
Capital Stock
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Common Stock
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
12.43
-0.65%
12.51
-0.89%
12.62
+1.03%
12.49
Ordinary Shares Number
12.43
-0.65%
12.51
-0.89%
12.62
+1.03%
12.49
Additional Paid In Capital
139.96
+2.43%
136.64
+1.73%
134.31
+2.47%
131.07
Gains Losses Not Affecting Retained Earnings
-1.18
+38.67%
-1.92
-40.78%
-1.36
-21.19%
-1.12
Total Equity Gross Minority Interest
34.64
+33.28%
25.99
-24.99%
34.65
+9.94%
31.52
Total Capitalization
34.64
+33.28%
25.99
-24.99%
34.65
+9.94%
31.52
Working Capital
23.68
+54.38%
15.34
-37.84%
24.68
+16.23%
21.23
Invested Capital
34.64
+33.28%
25.99
-24.99%
34.65
+9.94%
31.52
Total Debt
11.68
-14.21%
13.61
+4.01%
13.09
-16.93%
15.76
Capital Lease Obligations
11.68
-14.21%
13.61
+4.01%
13.09
-16.93%
15.76
Net Tangible Assets
34.40
+34.00%
25.67
-24.93%
34.19
+10.56%
30.93
Tangible Book Value
34.40
+34.00%
25.67
-24.93%
34.19
+10.56%
30.93
Available For Sale Securities
—
—
—
—
Investmentin Financial Assets
—
—
—
0.00
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Operating Cash Flow
11.88
-2.62%
12.20
+78.63%
6.83
-14.21%
7.96
Cash Flow From Continuing Operating Activities
11.88
-2.62%
12.20
+78.63%
6.83
-14.21%
7.96
Net Income From Continuing Operations
9.80
+233.84%
2.94
+15.63%
2.54
-18.59%
3.12
Depreciation Amortization Depletion
3.16
-11.87%
3.58
+0.06%
3.58
+9.75%
3.26
Depreciation
3.10
-8.82%
3.40
+0.00%
3.40
-32.63%
5.05
Amortization Cash Flow
0.10
+0.00%
0.10
+0.00%
0.10
—
Depreciation And Amortization
3.16
-11.87%
3.58
+0.06%
3.58
+9.75%
3.26
Amortization Of Intangibles
0.10
+0.00%
0.10
+0.00%
0.10
—
Other Non Cash Items
1.47
+13.76%
1.29
-25.97%
1.75
-2.13%
1.79
Stock Based Compensation
5.70
+73.84%
3.28
+2.89%
3.19
+80.32%
1.77
Asset Impairment Charge
—
—
0.00
-100.00%
2.21
Deferred Income Tax
-1.70
-33.36%
-1.28
+24.97%
-1.70
-2001.23%
-0.08
Operating Gains Losses
-0.00
-300.00%
0.00
-93.94%
0.03
—
Gain Loss On Sale Of PPE
-0.00
-300.00%
0.00
-93.94%
0.03
0.00
Change In Working Capital
-6.55
-375.21%
2.38
+193.04%
-2.56
+37.61%
-4.10
Change In Receivables
-0.56
+62.27%
-1.50
-148.73%
3.07
+331.20%
-1.33
Changes In Account Receivables
-0.24
+83.01%
-1.42
-191.40%
1.56
+353.75%
-0.61
Change In Inventory
-5.22
-887.92%
0.66
+985.25%
0.06
+105.14%
-1.19
Change In Prepaid Assets
-3.60
-258.03%
2.28
+78.68%
1.28
+331.58%
-0.55
Change In Payables And Accrued Expense
4.54
+95.14%
2.33
+144.71%
-5.21
-747.39%
0.80
Change In Accrued Expense
6.04
+3530.11%
-0.18
+77.14%
-0.77
-315.69%
0.36
Change In Payable
-1.50
-159.77%
2.50
+156.44%
-4.43
-1092.17%
0.45
Change In Account Payable
-1.29
-156.28%
2.30
+157.79%
-3.98
-583.25%
0.82
Change In Other Current Assets
0.07
+230.91%
-0.06
+64.97%
-0.16
-212.95%
0.14
Change In Other Current Liabilities
-1.78
-32.94%
-1.34
+16.36%
-1.60
+19.10%
-1.98
Investing Cash Flow
-1.37
+39.11%
-2.25
+26.61%
-3.06
-99.93%
-1.53
Cash Flow From Continuing Investing Activities
-1.37
+39.11%
-2.25
+26.61%
-3.06
-99.93%
-1.53
Net PPE Purchase And Sale
-1.37
+39.11%
-2.25
+26.61%
-3.06
-99.93%
-1.53
Purchase Of PPE
-1.37
+38.93%
-2.25
+26.80%
-3.07
-100.46%
-1.53
Sale Of PPE
0.00
0.00
-100.00%
0.01
0.00
Capital Expenditure
-1.37
+38.93%
-2.25
+26.80%
-3.07
-100.46%
-1.53
Financing Cash Flow
-7.60
+47.30%
-14.42
-511.67%
-2.36
+73.67%
-8.95
Cash Flow From Continuing Financing Activities
-7.60
+47.30%
-14.42
-511.67%
-2.36
+73.67%
-8.95
Net Issuance Payments Of Debt
—
—
—
0.00
Repayment Of Debt
—
—
—
0.00
Long Term Debt Payments
—
—
—
0.00
Net Long Term Debt Issuance
—
—
—
0.00
Net Common Stock Issuance
-5.81
+24.05%
-7.65
-647.90%
-1.02
+88.73%
-9.08
Common Stock Payments
-5.81
+24.05%
-7.65
-647.90%
-1.02
+88.73%
-9.08
Common Stock Dividend Paid
-2.07
+70.22%
-6.94
-337.58%
-1.59
—
Cash Dividends Paid
-2.07
+70.22%
-6.94
-337.58%
-1.59
-319.58%
-0.38
Repurchase Of Capital Stock
-5.81
+24.05%
-7.65
-647.90%
-1.02
+88.73%
-9.08
Proceeds From Stock Option Exercised
0.28
+3.32%
0.27
+7.54%
0.25
-50.10%
0.51
Net Other Financing Charges
—
-0.10
—
—
Changes In Cash
2.91
+165.24%
-4.46
-416.22%
1.41
+155.97%
-2.52
Effect Of Exchange Rate Changes
0.40
+258.27%
-0.25
-8566.67%
0.00
+100.65%
-0.46
Beginning Cash Position
16.89
-21.84%
21.61
+7.01%
20.19
-12.88%
23.17
End Cash Position
20.20
+19.63%
16.89
-21.84%
21.61
+7.01%
20.19
Interest Paid Supplemental Data
0.00
-90.48%
0.02
+320.00%
0.01
—
Income Tax Paid Supplemental Data
4.92
+113.27%
2.31
+23.12%
1.87
—
Change In Income Tax Payable
-0.20
-199.50%
0.20
+144.59%
-0.45
-20.16%
-0.38
Change In Tax Payable
-0.20
-199.50%
0.20
+144.59%
-0.45
-20.16%
-0.38
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category